csg-admin-2019

January 29, 2021

Exacis Biotherapeutics Announces Key Addition to its Executive Leadership Team with Dirk Huebner MD Joining as Chief Medical Officer

Exacis Biotherapeutics Names key executive Dirk Huebner MD, as Chief Medical Officer Immuno-oncology cell therapy company creates innovative, stealth and performance engineered T and NK […]
Do you like it?0
Read more
January 6, 2021

Exacis Biotherapeutics Announces Its Launch and mRNA Technology In-Licensing for Targeted CAR-NK and CAR-T Cell Cancer Therapies

Exacis Biotherapeutics Focuses on immuno-oncology Creates innovative, engineered T and NK cells from induced pluripotent stem cells (iPSC) In-licenses mRNA technologies developed by Factor Bioscience […]
Do you like it?0
Read more
September 14, 2020

CSG is pleased to welcome Heather Conover and Frank Pietrucha who will be working with us as Senior Consultants

A message from CSG President Ted Agne: We are very pleased to welcome Heather Conover and Frank Pietrucha who will be working with us as […]
Do you like it?0
Read more
May 11, 2020

CSG Announces Partnership with UK-Based Charles Consultants

Boston, May 11, 2020 – The Communications Strategy Group Inc. (CSG), announced today that it has formed a partnership agreement with UK-based Charles Consultants, a […]
Do you like it?0
Read more
Prev page
123456
Next page